ArticleRedox biology2020

EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis.

Chi-Chen Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.